Northwestern Mutual Wealth Management
TARS icon

Northwestern Mutual Wealth Management’s Tarsus Pharmaceuticals TARS Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.08K Sell
33
-149
-82% -$9.52K ﹤0.01% 3641
2026
Q1 		$12.8K Buy
+182
New +$12.7K ﹤0.01% 2980

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Northwestern Mutual Wealth Management's TARS Position: Q2 2026 in Review

Northwestern Mutual Wealth Management reduced its Tarsus Pharmaceuticals (TARS) stake by 82% in Q2 2026, selling an estimated $9.52K and leaving 33 shares worth $2.08K. The position accounts for ﹤0.01% of the portfolio, ranked #3641.

Northwestern Mutual Wealth Management first reported a position in TARS in Q1 2026 and has held it in 2 quarters since. The position peaked at $12.8K in Q1 2026. 257 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

  • Northwestern Mutual Wealth Management held 33 shares of Tarsus Pharmaceuticals worth $2.08K as of Q2 2026.
  • Northwestern Mutual Wealth Management sold 149 Tarsus Pharmaceuticals shares in Q2 2026, an estimated $9.52K.
  • Tarsus Pharmaceuticals made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q2 2026, its #3641 holding.
  • Northwestern Mutual Wealth Management first reported a position in Tarsus Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • Northwestern Mutual Wealth Management's Tarsus Pharmaceuticals position peaked at $12.8K in Q1 2026.
  • 257 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.